In an international cross‐sectional web survey of people with T2DM, those who discontinued treatment with basal insulin reported weight gain (48.4%) and hypoglycaemia (25.8%) as the main reason for discontinuation.25 Another web‐based survey also suggested that hypoglycaemia can negatively impact many aspects of daily life and that choosing the appropriate treatment is necessarily in order to prevent or control future episodes.26 Here, INS is linked to type 2 diabetes mellitus.